Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

More than 160 tech companies asked a court to reject Trump’s second travel ban

Amazon, Facebook, Google and Snap are among those filing.

President Trump Visits Snap-On Tools In Kenosha, Wisconsin
President Trump Visits Snap-On Tools In Kenosha, Wisconsin
Scott Olson / Getty

Amazon, Facebook, Google, Snap and more than 150 other tech companies told a federal court in Virginia today that it should toss U.S. President Donald Trump’s latest attempt to ban refugees and travelers from many majority-Muslim countries.

In a brief filed in the U.S. District Court of Appeals for the Fourth Circuit, a host of Silicon Valley heavyweights lambasted Trump’s new order — his second attempt, after a judge blocked his first one — and stressed it would inflict “substantial harm on U.S. companies, their employees, and the entire economy.”

The order, they continued, “hinders the ability of American companies to attract talented employees, increases costs imposed on business, makes it more difficult for American firms to compete in the international marketplace and gives global enterprises a new, significant incentive to build operations — and hire new employees — outside the United States.”

The brief — filed today by a total 162 tech firms, including Uber, SpaceX, Spotify and Twitter — represents the Valley’s latest legal salvo against Trump’s immigration policies.

When Trump issued his initial ban in January, the leaders of Apple, Facebook and Google emerged as some of its earliest critics. They sounded off in public statements while their employees protested, and they joined the likes of Amazon and Microsoft in a legal brief challenging the president’s first attempt at a ban. A judge in Washington state ultimately halted implementation of that executive order, leading to the second version that Trump unveiled in March.

Meanwhile, many in the tech industry have fought to ward off other major changes to U.S. immigration policy, including new restrictions on the country’s high-skilled visa program.

Trump, however, signed another executive order on Tuesday that begins a process to rethink how those visas, called H-1Bs, are awarded. And his administration has promised greater scrutiny for companies that employ foreign workers instead of Americans.

Amicus brief of 162 technology companies by April Glaser on Scribd


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh